Cahill Represents Financing Sources in Connection with Merger of IMS Health and Quintiles
Date: 10/03/16
Cahill represented the administrative agent and lead arrangers in connection with a new $450,000,000 Term A euro loan, a new $900,000,000 Term A dollar loan, a new $450,000,000 dollar-denominated revolving credit facility, a new $150,000,000 yen-denominated revolving credit facility and a new $400,000,000 multicurrency-denominated revolving credit facility for IMS Health Incorporated, a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. Proceeds from the offering were used in connection with the pending merger between IMS Health Holdings, Inc. and Quintiles Transnational Holdings, Inc., one of the world's largest contract research providers. The combined company, named Quintiles IMS Holdings, Inc., has a market value of over $18 billion.
Cahill also represented the joint book-running managers and co-managers in connection with the Rule 144A offering of $1,050,000,000 aggregate principal amount of 5.000% Senior Notes due 2026 and €625,000,000 aggregate principal amount of 3.500% Senior Notes due 2024 by IMS Health Incorporated. Proceeds from the offering were used to refinance existing indebtedness.